| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/27/2013 | US8518371 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
| 08/22/2013 | WO2013123523A1 Uses of porous nanostructure in delivery |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130216480 Amphiphilic polymers and methods of use thereof |
| 08/22/2013 | US20130216478 Non-Invasive Diagnostic Agents of Cancer and Methods of Diagnosing Cancer, Especially Leukemia and Lymphoma |
| 08/22/2013 | US20130216475 Methods and compositions for protein labelling |
| 08/22/2013 | US20130216474 Nanocells for diagnosis and treatment of diseases and disorders |
| 08/21/2013 | EP2627358A1 Pretargeting kit, method and agents used therein |
| 08/21/2013 | CN103254140A Novel <18>F marked substituted quinazoline compound, and preparation method and tumor PET development application thereof |
| 08/21/2013 | CN103254139A Novel <18>F marked 4-aminoquinazoline derivatives, and preparation methods and tumor PET development application thereof |
| 08/21/2013 | CN103251453A Method and apparatus for EMR treatment of skin |
| 08/21/2013 | CN102212159B Preparation method and application of solid-phase organic tin compound |
| 08/21/2013 | CN101868254B Positron emission tomography probes for imaging immune activation and selected cancers |
| 08/20/2013 | US8513217 Biopolymer system for tissue sealing |
| 08/20/2013 | US8513211 Oligonucleotide chelate complexes |
| 08/20/2013 | US8512676 Detection of rate changes in systematic oscillations of metabolic athways by monitoring isotope ratios |
| 08/20/2013 | US8512675 N and/or Nα derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH2)3 (CO)3]+ by fac coordination |
| 08/20/2013 | CA2516563C Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 08/15/2013 | US20130209363 Method for production of f-18 labeled amyloid beta ligands |
| 08/15/2013 | US20130209362 2-alkoxy-11-hydroxyaporphine derivatives and uses thereof |
| 08/15/2013 | US20130209361 Process for producing radiohalogenated bioconjugates and products thereof |
| 08/15/2013 | US20130209360 Compositions and Methods for Imaging |
| 08/15/2013 | US20130209359 Small Peptides Specifically Bind to Colorectal Cancers |
| 08/15/2013 | US20130209356 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy |
| 08/14/2013 | CN103242255A Evans blue complex as well as preparation method and application thereof |
| 08/14/2013 | CN101700401B Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 08/13/2013 | US8507454 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 08/13/2013 | US8506930 Compounds having affinity for amyloid |
| 08/13/2013 | US8506929 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 08/13/2013 | US8506928 Methods and compounds for targeting tissues |
| 08/13/2013 | US8506927 Pegylated fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 08/13/2013 | US8506926 [18F]-furanosylpurine derivatives and uses thereof |
| 08/13/2013 | CA2709871C Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 08/08/2013 | WO2013114245A1 Process of modulating man5 and/or afucosylation content of glycoprotein composition |
| 08/08/2013 | WO2013114204A1 A method of using adenosine and dipyridamole for pharmacologic stress testing, with specific compositions, unit dosage forms and kits |
| 08/08/2013 | WO2013113801A2 Chelating agents |
| 08/08/2013 | WO2013113680A1 Radiolabeled bile acids and bile acid derivatives |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130202530 Novel radiotracer |
| 08/08/2013 | US20130202529 Benztropine compounds and uses thereof |
| 08/08/2013 | CA2848985A1 C10rf32 antibodies, and uses thereof for treatment of cancer |
| 08/07/2013 | EP2621955A1 Anti-ceacam6 antibodies and uses thereof |
| 08/07/2013 | EP2621545A1 Apoptosis imaging agents based on lantibiotic peptides |
| 08/07/2013 | EP2621544A1 In vivo imaging method for cancer |
| 08/07/2013 | EP2621543A1 Method for rapid preparation of suitable [18f]fluoride for nucleophilic [18f]fluorination |
| 08/07/2013 | CN102772809B Preparation method of nano magnetic control agglomeration chemotherapeutic pharmaceutical composition |
| 08/07/2013 | CN102167711B <99m>Tc0 nucleus labeled melphalan dithiocarbamate (MPLDTC) complex, preparation method and application |
| 08/07/2013 | CN102146098B Preparation method and application of 99mTc labeled D-glucose coordination compound |
| 08/06/2013 | US8501909 Polypeptides having affinity for HER2 |
| 08/06/2013 | US8501691 Methods for treatment of headaches by administration of oxytocin |
| 08/06/2013 | US8501154 Fluorinated fructose derivatives for PET imaging |
| 08/06/2013 | US8501153 Active enantiomer |
| 08/06/2013 | US8501152 Method of radiolabelling carbon nanotubes, radiolabelled carbon nanotubes and applications thereof |
| 08/06/2013 | CA2591534C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 08/06/2013 | CA2522580C A medicament for the two-step perioperative therapy of solid tumours |
| 08/01/2013 | WO2013110615A1 Radiofluorination method |
| 08/01/2013 | US20130197271 Dendrimers and methods of preparing same through proportionate branching |
| 08/01/2013 | US20130195758 Paa nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded |
| 08/01/2013 | US20130195756 99mTc IMAGING AGENTS AND METHODS OF USE |
| 08/01/2013 | US20130195755 Micellular combination comprising a nanoparticle and a plurality of surfmer ligands |
| 08/01/2013 | US20130195752 Functionalized nanoparticles and methods of use thereof |
| 08/01/2013 | US20130195751 Self-assembed conjugate and use thereof |
| 07/31/2013 | EP2619210A1 Process for chelating copper ions using cb-te2a bifunctional chelate |
| 07/31/2013 | EP2618850A1 In vivo imaging method of mood disorders |
| 07/31/2013 | CN103228298A Apoptosis PET imaging agents |
| 07/31/2013 | CN103224495A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8496910 Stabilisation of radiopharmaceutical precursors |
| 07/30/2013 | CA2534639C Anti-cd19 antibodies |
| 07/25/2013 | US20130189186 Apoptosis imaging agents based on lantibiotic peptides |
| 07/25/2013 | US20130189185 Boron-Based Dual Imaging Probes, Compositions and Methods for Rapid Aqueous F-18 Labeling, and Imaging Methods Using Same |
| 07/25/2013 | US20130189184 Pretargeting kit, method and agents used therein |
| 07/24/2013 | CN103221072A In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents |
| 07/24/2013 | CN103212093A Magnetic nano-grade material with cell-targeting property, and biomedical application thereof |
| 07/24/2013 | CN103212072A An antigen associated with lung cancers and lymphomas |
| 07/24/2013 | CN102727911B Diamino polyethylene glycol modified paramagnetic metal complex magnetic resonance imaging contrast agent |
| 07/23/2013 | US8492341 Amyloid-β binding peptides |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | US8491884 Virus clearance of neoplastic cells from mixed cellular compositions |
| 07/23/2013 | US8491869 Imaging agents for detecting neurological disorders |
| 07/23/2013 | US8491868 Ligands for imaging cardiac innervation |
| 07/23/2013 | US8491867 Method of nuclear medical photography using dual-isotopes |
| 07/18/2013 | WO2013104586A1 Methods for preventing, treating or diagnosing disorders |
| 07/18/2013 | WO2008120084A3 Method and apparatus for isolating 186rhenium |
| 07/18/2013 | US20130183240 In vivo imaging method for cancer |
| 07/18/2013 | US20130183239 Isotopic carbon choline analogs |
| 07/18/2013 | US20130183238 Formulation, Apparatus and Method for Stabilizing Radiopharmaceuticals |
| 07/18/2013 | US20130183237 Thrombin inhibitor |
| 07/18/2013 | US20130183236 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 07/18/2013 | US20130183235 Alpha-emitting complexes |
| 07/18/2013 | US20130183234 Compositions Useful for Target, Detection, Imaging and Treatment, and Methods of Production and Use Thereof |
| 07/18/2013 | CA2860843A1 Methods for preventing, treating or diagnosing disorders |
| 07/17/2013 | EP2044961B1 Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas |
| 07/17/2013 | CN103209713A In vivo imaging method of mood disorders |
| 07/17/2013 | CN103204934A Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44 |
| 07/17/2013 | CN103203032A Technetium [99Tc] methylenediphosphonate preparation and preparation method thereof |
| 07/17/2013 | CN102558431B Preparation method of tumor developer folate--poly hydroxyethyl acrylate-diethylenetriamine pentaacetic acid |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN101918443B Antigen associated with rheumatoid arthritis |